Thursday, June 21, 2018
Health

Odds in clinical trials shown to be beneficial for patients

TAMPA — Signing up for a clinical trial is a difficult decision. Many patients fear they will be assigned to receive an older treatment — and not get a shot at the newer, hopefully better drug in final testing stages.

Now an international group of experts can put those fears to rest. Your chances of getting the superior treatment are about 50-50, researchers found, regardless of which drug you receive.

Dr. Benjamin Djulbegovic, an oncologist at the University of South Florida and Moffitt Cancer Center, led the team of researchers that reviewed 743 clinical trials involving 297,744 patients. Their report was published this week by the highly regarded Cochrane Collaboration.

"From the patient point of view, this is good news," Djulbegovic said. "On average, if you are being enrolled in clinical trials, there is a 50 percent chance that you are going to get superior treatment. That superior treatment could very well be the new treatment, or the existing treatment — but that will not be known in advance."

The findings are significant from a scientific standpoint. If newer was always better, Djulbegovic noted, it would be unethical to conduct randomized trials for drugs in final testing stages in which patients are assigned to groups receiving either new or existing therapies. Both sets of outcomes are compared.

"Why would you do a trial if you knew the answer?" he asked. "And ethically, you would be knowingly exposing patients to inferior treatment because you believe you know the answer."

Djulbegovic, USF's associate dean for clinical research, became interested in the topic a decade ago when enrolling a local patient in a clinical trial. The man asked how often the patients receiving the experimental drugs were better off.

"I was taken aback. I didn't know," Djulbegovic said.

To find an answer, Djulbegovic and his team reviewed clinical trials involving new therapies for cancers, neurological disorders and other diseases. They reviewed only publicly funded studies, for which both positive and negative outcomes were available.

Such perspective was necessary because medical journals can be biased in favor of positive results, Djulbegovic said. And pharmaceutical companies don't always release the results of their clinical trials if the new drug wasn't found to be better.

Now doctors and patients can know exactly what they are getting into when enrolling in randomized clinical trials.

"Society can expect that slightly more than half of new experimental treatments will prove to be better," the reviewers concluded. "But few will be substantially better."

Letitia Stein can be reached at [email protected] or (727) 893-8330.

Comments
‘BE AWARE’: Pasco mom posts to Facebook after son’s caterpillar sting leads to ER trip

‘BE AWARE’: Pasco mom posts to Facebook after son’s caterpillar sting leads to ER trip

ZEPHYRHILLS — The Pergolas’ Saturday morning volunteer work started like most, at a farm cleaning the property and trimming trees. Andrea Pergola, 38, stood on the driveway of the property when she heard her 15-year-old son Logan scream. At first, sh...
Published: 06/20/18
Moffitt receives $1 million donation from Richard Gonzmart

Moffitt receives $1 million donation from Richard Gonzmart

TAMPA — Runners gathered for the Gonzmart’s Father’s Day Walk and Jog where they raise money to help aid in Moffitt Cancer Center’s fight against prostate cancer. This year the event raised $110,000, but Moffitt had another surprise in store.Andrea G...
Updated: 5 hours ago
Compulsive video-game playing could be mental health problem

Compulsive video-game playing could be mental health problem

GENEVA — Obsessive video gamers know how to anticipate dangers in virtual worlds. The World Health Organization says they now should be on guard for a danger in the real world: spending too much time playing. In its latest revision to a disease class...
Published: 06/19/18
Funded by Alcohol Industry, Federal Study on Drinking Is Shut Down

Funded by Alcohol Industry, Federal Study on Drinking Is Shut Down

The extensive government trial was intended to settle an age-old question about alcohol and diet: Does a daily cocktail or beer really protect against heart attacks and stroke?To find out, the National Institutes of Health gave scientists $100 millio...
Published: 06/16/18
More than a third of American adults take prescription drugs that may increase risk of depression, study says

More than a third of American adults take prescription drugs that may increase risk of depression, study says

More than a third of American adults are taking prescription drugs, including hormones for contraception, blood pressure medications and medicines for heartburn, that carry a potential risk of depression, according to a study published in the Journal...
Published: 06/12/18
It’s time to use the stingray shuffle to avoid a nasty sting

It’s time to use the stingray shuffle to avoid a nasty sting

Courtney Bilyeu was running toward the murky water alongside a few military officers when it happened.She was an accountant for the U.S. Navy at the time. And on her way to take a swim with some coworkers in a California beach, she saw blood. The wat...
Published: 06/12/18
It’s important to wear sunglasses even on cloudy days, ophthalmologists say

It’s important to wear sunglasses even on cloudy days, ophthalmologists say

The next time you head to the drugstore to buy sunscreen, don’t forget to pick up some sunglasses, too. That’s because both products work to protect your body from the sun’s damaging ultraviolet rays.Wearing sunglasses for protection should not be re...
Published: 06/09/18
In St. Pete, kidney patients gather for science and solidarity

In St. Pete, kidney patients gather for science and solidarity

ST. PETERSBURG — Kidney disease doesn’t discriminate.The crowd of more than 200 patients who gathered at the Vinoy Renaissance St. Petersburg Resort range in age from teenagers to seniors. They are of different ethnicities and come from all over the...
Published: 06/08/18
Mayo Clinic Q&A: melanomas of the eye; how long should you take a beta blocker?

Mayo Clinic Q&A: melanomas of the eye; how long should you take a beta blocker?

YES, MELANOMAS CAN BEGIN IN THE EYEIs it true that melanoma can develop in the eyes? If so, how common is it? How is it treated?Melanomas can begin in the eye, a condition called intraocular melanoma. Treatment for intraocular melanomas used to prima...
Published: 06/08/18
For writer, using a heart rate monitor takes HIIT from frightening to fun

For writer, using a heart rate monitor takes HIIT from frightening to fun

High-intensity interval training is one of the biggest trends in fitness, but it has always seemed a bit scary to me. To a mere mortal with achy knees and an aging body, even the acronym — HIIT — sounded intimidating.But recently, I overcame my fears...
Published: 06/08/18